BNP Paribas Asset Management
AXSM icon

BNP Paribas Asset Management’s Axsome Therapeutics AXSM Stock Holding History

BNP Paribas Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
627
+2
+0.3% +$434 ﹤0.01% 1446
2026
Q1 		$106K Buy
625
+157
+34% +$27.1K ﹤0.01% 1494
2025
Q4 		$85K Buy
468
+142
+44% +$19.8K ﹤0.01% 1516
2025
Q3 		$40K Hold
326
– – ﹤0.01% 1123
2025
Q2 		$34K Buy
+326
New +$34.5K ﹤0.01% 1280

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BNP Paribas Asset Management's AXSM Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Axsome Therapeutics (AXSM) stake by 0.32% in Q2 2026, buying an estimated $434 and bringing the position to 627 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

BNP Paribas Asset Management first reported a position in AXSM in Q2 2025 and has held it in 5 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • BNP Paribas Asset Management held 627 shares of Axsome Therapeutics worth $153K as of Q2 2026.
  • BNP Paribas Asset Management bought 2 Axsome Therapeutics shares in Q2 2026, an estimated $434.
  • Axsome Therapeutics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1446 holding.
  • BNP Paribas Asset Management first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.